期刊文献+

不同地域患者罗库溴铵药效学的比较——多中心研究 被引量:7

Difference in pharmacodynamics of rocuronium among patients from different geographic regions: a multicenter study
原文传递
导出
摘要 目的比较中国、奥地利和美国3个不同地域的当地患者罗库溴铵作用的量效关系和时效关系。方法选择中国大连、美国英格伍德、奥地利格拉茨3个医学中心择期手术患者各18例,异丙酚、芬太尼静脉麻醉诱导后,累积剂量法进行药效学观察,首剂静脉注射罗库溴铵50μg/kg,起效后重复首剂静脉给药6次,再静脉注射罗库溴铵300μg,采用肌机械运动监测仪记录肌肉收缩强度,对数剂量.概率单位绘制剂量-反应曲线。比较3个地域患者罗库溴铵的ED50、ED90和ED95以及Dur25和Dur0.8。结果大连和格拉茨患者罗库溴铵的ED50、ED90和ED95均高于英格伍德患者,格拉茨患者的ED50、ED90和ED95高于大连患者(P<0.05);大连和格拉茨患者的Dur25和Dur0.8均短于英格伍德患者(P<0.05),格拉茨患者的Dur25短于大连患者(P<0.05),但两者Dur0.8的差异无统计学意义(P>0.05)。结论3个地域患者罗库溴铵作用的量效关系和时效关系有明显的差别,临床用量需要考虑地域因素的影响。 Objective To compare the potency and duration of action of rocuronium bromide in patients from three countries -P. R. China ( Han nationality ), U. S. A, (Caucasians) and Austria (Caucasians) . Methods The 1st affiliated hospital of Dalian Medical University (P. R. China), Englewood Medical Center (U.S.A.) and Graz Medical University (Austria) took part in this study. Eighteen ASAⅠ or Ⅱ patients (9 male, 9 female) aged 30-50 yr from each medical center were studied. Anesthesia was induced with fentanyl 1.5μg/kg and propofol 2-3 mg/kg. Laryngeal mask airway (LMA) was inserted and the patients were mechanically ventilated. Anesthesia was maintained with intravenous infusion of propofol ( 100-150 μg·kg^-1·min^-1) and remifentanil (0.1-0.3 μg·kg^-1·min^-1 ). Six consecutive incremental doses of rocuronium 50 μg/kg were given. T1 was recorded after each dose. After the 6th dose, rocuronium 300 μg/kg was given. The responses of the adductor pollicis muscle to train-of-four (TOF) stimulation of ulnar nerve were measured and recorded with relaxometer mechanomyograph (Holland). Dose-response curves were created using log-dose-probit transformation ED50, ED90 and ED95 (effective doses required for 50% , 90% and 95% T1 depression respectively) and Dur 25 and Dur 0.8 (the time from the administration of the last dose to the recovery of T1 = 25% and T4/T1 = 0.8) of rocuronium were compared among the patients from the 3 countries. Results ED50, ED90 and ED95 of rocuronium were significantly higher in Chinese patients [(201 ± 59), (413 ± 107) and (475 ± 155)μg/kg] and Austrian patients [(258 ± 68), (530 ± 159) and (598 ± 189 )μg/kg] than in American patients [(148 ± 48), (316 ± 116) and (362 ± 149μg/kg) ]. Dur 25 and Dur 0.8 were significantly shorter in Chinese patients [ (30 ± 8) and (46 ± 16) mini and Austrian patients [(22 ± 6) and (37 ± 13) mini than in American patients [(37 ± 8) and (56 ± 17)min ]. Conclusion There is a significant difference in the potency and duration of action of rocuronium among the patients from the 3 countries. The influence of geographic regions should be considered on recommended dosage of rocuronium.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2007年第3期229-231,共3页 Chinese Journal of Anesthesiology
关键词 雄甾烷醇类 剂量效应关系 药物 神经肌肉阻滞 地理位置 Androstanols Dose-response relationship, drug Neuromuscular blockade Geographic locations
  • 相关文献

参考文献8

  • 1Katz RL, Norman J, Seed RF, et al. A comparison of the effects of suxamethonium and tubocurarine in patients in London and New York. Br J Anaesth, 1969,41 : 1041-1047.
  • 2Fiset P, Donati F, Balendran P, et al. Vecuronium is more potent in Montreal than in Paris. Can J Anaesth, 1991,38:717-721.
  • 3Puhringer FK, Khuenl-Brady KS, Mitterschiffthaler G. Rocuronium bromide: time-course of action in underweight, normal weight, over weight and obese patients. Eur J Anaesthesiol, 1995,11 Suppl: 107-110.
  • 4Rowaan CJ, Vandenbrom RH, Wierda JM. The Relaxometer: a complete and comprehensive computer-controlled neuromuscular transmission measurement system developed for clinical research on muscle relaxants. J Clin Monit, 1993,9:38-44.
  • 5Donlon JV Jr, Savarese JJ, Ali HH, et al. Human dose-response curves for neuromuscular blocking drugs: a comparison of two methods of construction and analysis. Anesthesiology, 1980,53 : 161-166.
  • 6Xie HG, Kim RB, Wood AJ, et al. Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol,2001,41 : 815-850.
  • 7Proost JH, Eriksson LI, Mirakhur RK, et al. Urinary, biliary and faecal excretion of rocuroniura in humans. Br J Anaesth, 2000,85 : 717-723.
  • 8Collins LM, Bevan JC, Bevan DR, et al. The prolonged duration of rocuronium in Chinese patients. Anesth Analg,2000,91:1526-1530.

同被引文献92

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部